Bacteriophages of the Urinary Microbiome by Miller-Ensminger, Taylor et al.
Loyola University Chicago 
Loyola eCommons 
Bioinformatics Faculty Publications Faculty Publications 
5-2018 
Bacteriophages of the Urinary Microbiome 
Taylor Miller-Ensminger 
Loyola University Chicago, tmillerensminger@luc.edu 
Andrea Garretto 
Loyola University Chicago 
Jonathon Brenner 
Loyola University Chicago 
Krystal Thomas-White 
Loyola University Chicago 
Adriano Zambom 
Loyola University Chicago, azambom@luc.edu 
See next page for additional authors 
Follow this and additional works at: https://ecommons.luc.edu/bioinformatics_facpub 
 Part of the Biology Commons 
Recommended Citation 
Miller-Ensminger, Taylor; Garretto, Andrea; Brenner, Jonathon; Thomas-White, Krystal; Zambom, Adriano; 
Wolfe, Alan J.; and Putonti, Catherine. Bacteriophages of the Urinary Microbiome. Journal of Bacteriology, 
200, 7: 13, 2018. Retrieved from Loyola eCommons, Bioinformatics Faculty Publications, http://dx.doi.org/
10.1128/JB.00738-17 
This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has 
been accepted for inclusion in Bioinformatics Faculty Publications by an authorized administrator of Loyola 
eCommons. For more information, please contact ecommons@luc.edu. 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. 
© American Society for Microbiology 2018 
Authors 
Taylor Miller-Ensminger, Andrea Garretto, Jonathon Brenner, Krystal Thomas-White, Adriano Zambom, 
Alan J. Wolfe, and Catherine Putonti 
This article is available at Loyola eCommons: https://ecommons.luc.edu/bioinformatics_facpub/36 
Bacteriophages of the Urinary Microbiome
Taylor Miller-Ensminger,a Andrea Garretto,a Jonathon Brenner,b Krystal Thomas-White,c Adriano Zambom,d Alan J. Wolfe,c
Catherine Putontia,b,c,e
aBioinformatics Program, Loyola University Chicago, Chicago, Illinois, USA
bDepartment of Computer Science, Loyola University Chicago, Chicago, Illinois, USA
cDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA
dDepartment of Mathematics and Statistics, Loyola University Chicago, Chicago, Illinois, USA
eDepartment of Biology, Loyola University Chicago, Chicago, Illinois, USA
ABSTRACT Bacterial viruses (bacteriophages) play a signiﬁcant role in microbial
community dynamics. Within the human gastrointestinal tract, for instance, associa-
tions among bacteriophages (phages), microbiota stability, and human health have
been discovered. In contrast to the gastrointestinal tract, the phages associated with
the urinary microbiota are largely unknown. Preliminary metagenomic surveys of the
urinary virome indicate a rich diversity of novel lytic phage sequences at an abun-
dance far outnumbering that of eukaryotic viruses. These surveys, however, exclude
the lysogenic phages residing within the bacteria of the bladder. To characterize this
phage population, we examined 181 genomes representative of the phylogenetic di-
versity of bacterial species within the female urinary microbiota and found 457
phage sequences, 226 of which were predicted with high conﬁdence. Phages were
prevalent within the bladder bacteria: 86% of the genomes examined contained at
least one phage sequence. Most of these phages are novel, exhibiting no discernible
sequence homology to sequences in public data repositories. The presence of phages
with substantial sequence similarity within the microbiota of different women supports
the existence of a core community of phages within the bladder. Furthermore, the ob-
served variation between the phage populations of women with and without overactive
bladder symptoms suggests that phages may contribute to urinary health. To comple-
ment our bioinformatic analyses, viable phages were cultivated from the bacterial iso-
lates for characterization; a novel coliphage was isolated, which is obligately lytic in the
laboratory strain Escherichia coli C. Sequencing of bacterial genomes facilitates a compre-
hensive cataloguing of the urinary virome and reveals phage-host interactions.
IMPORTANCE Bacteriophages are abundant within the human body. However, while
some niches have been well surveyed, the phage population within the urinary mi-
crobiome is largely unknown. Our study is the ﬁrst survey of the lysogenic phage
population within the urinary microbiota. Most notably, the abundance of prophage
exceeds that of the bacteria. Furthermore, many of the prophage sequences identi-
ﬁed exhibited no recognizable sequence homology to sequences in data reposito-
ries. This suggests a rich diversity of uncharacterized phage species present in the
bladder. Additionally, we observed a variation in the abundances of phages between
bacteria isolated from asymptomatic “healthy” individuals and those with urinary
symptoms, thus suggesting that, like phages within the gut, phages within the blad-
der may contribute to urinary health.
KEYWORDS bacteria, bacteriophages, microbiome, prophage, urinary tract, virus
Surveys of the bacteria inhabiting the human body have led to the discovery of newtaxa (1), as well as a greater diversity among “healthy” individuals than originally
hypothesized (for a review, see reference 2). Studies have identiﬁed associations
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between the presence, absence, and/or prevalence of bacterial taxa and an individual’s
health and response to treatment (for reviews, see references 3–5). For instance,
Lactobacillus gasseri within the bladder is strongly associated with urinary urgency
incontinence (UUI) in women; this contrasts with Lactobacillus crispatus, which is
associated with asymptomatic controls (6). An imbalance of the microbiota (dysbiosis)
also can be connected with an individual’s health, as reported within the gastrointes-
tinal tract (7). In addition to bacteria, the microbial communities that colonize the
human body include other cellular organisms (archaea and fungi) and viruses, all of
which are involved in complex interactions with each other and surrounding human
cells. Of particular note are the interactions between bacteria and their natural pred-
ators: bacteriophages (viruses that infect bacteria). Bacteriophages (phages) are crucial
members of microbial communities, shaping bacterial metabolism and community
structure (8, 9). Within the gut, for instance, this inﬂuence extends from infancy through
adulthood (10, 11). Similar observations have been made within the microbiota of the
oral cavity (see a review in reference 12).
Human microbiome surveys have identiﬁed phages within every community exam-
ined (13). In fact, they are the most abundant members of the human virome, far
exceeding eukaryotic viruses (13). Despite their prevalence, phages are signiﬁcantly
understudied in comparison to their hosts. As such, phages detected within the human
microbiome are often novel, with their sequences exhibiting no recognizable similarity
to those of characterized species (13, 14). While phages can exploit a variety of infection
strategies, lytic and lysogenic phages are most frequently found. Lytic phages are
exclusively predatory, killing their host cell. Lysogenic phages have two lifestyle
choices: they can be lytic immediately, or they can incorporate their genome into
the host’s bacterial genome or remain in the cytoplasm as a plasmid. The phage genome
(now called a prophage) generally replicates in synchrony with the host chromosome until
some signal induces the phage to enter the lytic path. Within the gut microbiota, this shift
from lysogeny to the lytic path has been correlated with disease (14).
In comparison to the sites of the body investigated by the Human Microbiome
Project (HMP), the urinary bladder is understudied. While new urinary microbiome
research has primarily focused on the bacterial constituents of this community (5), a
few studies have shown that the urinary microbiota also includes viruses. First, viruses
have been isolated from urine, including several eukaryotic viruses (15–21) and phages
(22, 23). Second, two metagenomic sequencing studies of the urinary virome (eukary-
otic viruses and phages in the lytic cycle) have been conducted (24, 25). Although these
virome studies found that phages vastly outnumber (99%) eukaryotic viruses, they
have sampled but a fraction of the phage community; they did not capture the diversity
of prophages present.
While prophages can account for up to 20% of a bacterial genome (26), they are not
simply passengers along for the ride; they can be selectively advantageous or disad-
vantageous to the host cell (26). For example, harboring a prophage can provide the
bacterial host with protection from superinfection (27, 28). The presence of a prophage
also can increase bacterial ﬁtness through phage genes; for instance, the  phage genes
bor and lom increase the Escherichia coli host’s survival in macrophages (29). Further-
more, a prophage can encode a critical virulence factor. For example, the botulinum,
Shiga, and cholera toxins, among others, are encoded by prophages (30). In the event
that a prophage reduces its host’s ﬁtness, selection should lead to inactivation and/or
deletion (31). In fact, the Shiga toxin in Shigella dysenteriae 1 is the functional relic
of a once-functional prophage (32).
Based upon prior sequencing of bacterial isolates from the bladder and the abun-
dance of prophage sequences detected (33, 34), we hypothesize that the prophage
population in the urinary microbiota is large. This is a reasonable assumption, as
lysogenic phages have been found to outnumber obligately lytic phages within the
microbiota of the gut, particularly in the microbiota of healthy individuals (14). Because
the urinary microbiota (35–37) exists at a substantially lower biomass than the gut (38)
and prior research has found that the frequency of lysogeny is inversely related to
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susceptible host density (39–42), we anticipate that the abundance of lysogenic phages
may exceed that of the gut. To explore the lysogenic phage population of the urinary
microbiome, we sequenced 181 genomes that represent the phylogenetic diversity of
bacterial species isolated from the bladder (K. Thomas-White, S. C. Forster, N.
Kumar, M. Van Kuiken, C. Putonti, M. Stares, E. E. Hilt, T. K. Price, A. J. Wolfe, and T. D.
Lawley, unpublished data). Within these sequenced genomes, which represent 51
bacterial genera and 102 species, phage sequences were identiﬁed and characterized.
Whereas seeking phage sequences within bacterial genomes would preclude the
detection of most lytic phages, culture-dependent methods, such as those employed
here, provide a key piece of information about the phages identiﬁed: each phage’s
native host. The result is the ﬁrst catalogue of the rich diversity of uncharacterized
phage species present in the bladder microbiota.
RESULTS
The genome assemblies of 181 bacterial isolates from the bladder were examined
for the presence of phage sequences. These bacterial isolates were collected from
women both with and without lower urinary tract symptoms (LUTS) and were selected
to represent the phylogenetic diversity of bacteria within the urinary microbiota (see
Data Set S1 in the supplemental material) (Thomas-White et al., unpublished). The
taxonomy of each isolate was determined by 16S rRNA gene analysis (Data Set S2).
Clustered regularly interspaced short palindromic repeat (CRISPR) arrays were identiﬁed
within 109 of the 181 strains sequenced (Data Set S1). The tool VirSorter (43) was used
to detect the phage sequences of both prophages that are integrated into the bacterial
chromosome (categories 4 to 6) and phages that are not, including lytic phages and
prophages existing as an extrachromosomal plasmid (categories 1 to 3). Given that this
tool can detect both lytic and lysogenic phages, we refer to categories 1 to 3 as
“unintegrated phages” and categories 4 to 6 as “integrated prophages.” Category
designations indicate the conﬁdence of the prediction deﬁned by VirSorter (43).
Categories 1 and 4 are the most conﬁdent predictions, while 3 and 6 are the least. Here,
we deﬁne categories 1, 2, 4, and 5 as “high-conﬁdence” predictions and categories 3
and 6 as “lower-conﬁdence” predictions. In total, 226 high-conﬁdence phage sequences
and 231 lower-conﬁdence phage sequences were identiﬁed (Table 1 and Data Set S3).
The nucleotide sequences for these phages are included in Data Set S4. Each phage
sequence was annotated; the presence/absence of a terminase-coding region was used
as a marker to assess if the phage sequence identiﬁed by VirSorter was representative
of a complete phage genome. The majority of sequences in the high-conﬁdence group
(85%) contained a recognizable terminase-coding region. In contrast, many of the
phage sequences predicted with lower conﬁdence lacked an identiﬁable terminase-
coding region. Upon further investigation, most (71%) of the phage sequences within
this lower-conﬁdence group are partial phage genome sequences, which is either a
residual of the assemblies themselves (as genomes are in scaffolds) or defunct inte-
grated phages.
Phage sequences were abundant among the bacterial isolates from the bladder;
86% of these isolates had one or more phages associated with their genome sequence
(Fig. 1). The number of phage sequences found within a genome had a low correlation
TABLE 1 Number of phage sequences identiﬁed within the 181 genomes for each
conﬁdence category
Phage type Category No. of phage sequences No. of bacterial isolates
Unintegrated 1 7 3
2 41 28
3 67 47
Integrated 4 8 8
5 170 105
6 164 95
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with the genome’s size (Spearman’s   0.09 for high-conﬁdence predictions and  
0.21 for all predicted phages, with P values of 0.26 and 0.005, respectively). Additionally,
no signiﬁcant difference was found between the average length of the genomes of
bacterial isolates containing phage and those lacking phage (with P values of 0.43 and
0.13 for high-conﬁdence and lower-conﬁdence predictions, respectively).
In characterizing the phage population within the bladder, we ﬁrst focused on the
226 phage sequences predicted with high conﬁdence, as these were found to resemble
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FIG 1 Phage presence within bacteria of the bladder. Each phage sequence identiﬁed at a high conﬁdence is represented by a dot on the isolate’s branch in
the phylogenetic tree, which was built using the 16S rRNA gene sequences of the isolates. The phyla for the isolates in the phylogenetic tree are indicated in
the outer circle, with “B” indicating the single isolate from the phylum Bacteroidetes. Red and blue circles represent unintegrated phages of categories 1 and
2, respectively. Green and yellow circles represent integrated phages of categories 4 and 5, respectively. It is important to note that branches without dots may
include lower-quality predictions (categories 3 and 6).
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intact viable phages. These sequences were compared to all bacterial sequences in
public repositories, as well as all publicly available viral genomic sequences. Eighty-ﬁve
of the 226 high-conﬁdence phages exhibited sequence similarity to prophage se-
quences within previously sequenced bacterial genomes (Data Set S5; see Materials and
Methods for further details), many from the sequencing efforts that established the
human microbiome reference set. In contrast, only six phages resembled previously
characterized isolated phages at a strict threshold (50% phage genome query cov-
erage), while an additional six phages were identiﬁed at a more relaxed threshold
(25% phage genome query coverage). The majority of high-conﬁdence phage se-
quences (129/226 [57%]), however, exhibited no sequence similarity to any known
phages. Thus, we have uncovered 129 novel phages from the urinary microbiota. A
similar examination of the lower-conﬁdence phage sequences (Data Set S6) revealed 91
hits to previously sequenced bacterial genomes. Again, the majority of sequences in
this second lower-conﬁdence set (140/231 [61%]) appear to be novel.
The phage sequences identiﬁed within the bladder’s bacterial isolates, including
both the high- and lower-conﬁdence sets, were next compared to each other. Signif-
icant sequence homology was detected within the phages found in isolates of the
bacterial family Actinomycetaceae, including ﬁve Actinomyces strains and one Varibacu-
lum cambriense strain (Fig. 2), each isolated from a different patient. The ﬁrst ﬁve
phages in Fig. 2 were predicted within the higher-conﬁdence set; in contrast, the
prophage from Actinomyces europaeus strain UMB0652 was predicted to be in category
6 and thus in the lower-conﬁdence set. Next, these six phage sequences were anno-
tated via RAST (44), revealing several phage and phage-associated coding regions (Fig.
2). The 60-kbp region conserved among ﬁve of the six Actinomycetaceae phages
discovered in this study showed greatest similarity to a prophage within the genome
of Corynebacterium atypicum strain R2070 (family Corynebacteriaceae) with 65% cover-
age and 90% nucleotide identity (megablast). Homologous regions between the
Corynebacterium prophage and these Actinomycetaceae phages included “hallmark”
viral gene sequences. We thus turned our attention to the hallmark viral genes of the
capsid and terminase large subunit. blastx analysis of these genes to viral genomes in
GenBank identiﬁed sequence homology (E value, 0) to Streptococcus phages, indicative
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FIG 2 Phage conserved among Actinomycetaceae strains isolated from different patients. Syntenic regions are shown between the strains.
The annotations for coding regions within each syntenic block are listed in the corresponding colors. ECF, energy-coupling factor.
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of a common, albeit distant, ecological or evolutionary history between the Strepto-
coccus and Actinomycetaceae phages. In addition to these Actinomycetaceae phages,
several other phage sequences were found to include syntenic blocks across strains of
bacteria from the bladder, including species from the genera Gardnerella, Aerococcus,
Streptococcus, Lactobacillus, Biﬁdobacterium, and Escherichia (Table S1).
The Actinomycetaceae phages shown in Fig. 2 were all found in strains isolated from
women with overactive bladder (OAB), whereas the V. cambriense strain was obtained
from a woman with stress urinary incontinence (SUI). In contrast, these Actinomyceta-
ceae phages were not identiﬁed within any of the Actinomyces strains isolated from
asymptomatic controls. While the purpose of this study was to explore phage diversity
and prevalence within the bacteria of the bladder, the Actinomycetaceae phages
motivated us to examine the phage populations relative to the patient condition.
Looking more broadly at the data as “condition” versus “condition,” a subset of the
data was selected in which the patient had not received any treatment for urinary
conditions. Thus, the condition group included 69 genomes, and the condition
group included 73 genomes (Data Set S1). The probability distributions of the number
of high-conﬁdence phage sequences between the two groups were not found to be
statistically different, as assessed by calculating the generalized likelihood ratio test for
comparing two negative binomial distribution parameters. Next, the phage populations
were examined between the two cohorts by genus. A Wilcoxon test was performed;
although there appears to be variation in the mean number of phage sequences within
several genera, a marginally statistically signiﬁcant difference was only detected within
the genus Lactobacillus (P  0.06647). It is important to note that not all Lactobacillus
species chosen to be sequenced were collected from both populations; for example,
the Lactobacillus iners genomes examined here were only from women in the control
population, although L. iners is commonly found in the urinary microbiome of both
condition and condition women (6, 36). Figure 3 illustrates the number of high-
conﬁdence phages per isolate found within the condition (control) population and
the largest subset of condition patients, individuals with OAB symptoms (n  63).
(Similar analysis of the lower-conﬁdence phages can be found in Fig. S1.) The mean
count between the control and OAB populations was not statistically different for either
category (high-conﬁdence phages, P  0.2057; lower-conﬁdence phages, P  0.2084).
Whereas we identiﬁed with high conﬁdence an abundance of phage sequences
within the bladder bacteria, some prophages integrated into the bacterial chromosome
(categories 4 to 6) may be unable to enter the lytic cycle (i.e., defunct or defective
prophages). For instance, eight phages were identiﬁed within the genome of E. coli
strain UMB0901, including four predicted with high conﬁdence. All four of these phage
sequences are integrated prophages (categories 4 and 5) and exhibit the greatest
sequence similarity to annotated prophages within E. coli genomes from the human
microbiota (45) (Table 2). To determine if these prophages can enter the lytic cycle, E.
coli UMB0901 was selected for further analysis in the lab. One phage was isolated (see
Materials and Methods). While lysogenic within its UMB0901 host, this phage was
capable of lysing laboratory strains of E. coli C and E. coli K-12 under both aerobic and
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FIG 3 Average number of high-conﬁdence phage sequences per genome isolated from control and OAB
patients. Genera with representatives from both patient populations are shown.
Miller-Ensminger et al. Journal of Bacteriology
April 2018 Volume 200 Issue 7 e00738-17 jb.asm.org 6
 o
n
 July 24, 2018 by LO
YO
LA UNIV CHICAG
O
http://jb.asm.org/
D
ow
nloaded from
 
anaerobic conditions; infection of the laboratory strain E. coli B was observed on several
occasions, although not consistently. We also tested the phage’s lytic activity on the
other E. coli isolates from this study and several other E. coli bladder isolates in our
collection (see Materials and Methods); lysis was not observed for any of these clinical
isolates (data not shown). High-titer stocks of the puriﬁed phage were used to examine
the phage’s morphology via transmission electron microscopy (TEM) (Fig. 4). The
presence of a contractile tail indicates that this phage belongs to the family Myoviridae
of the order Caudovirales.
DISCUSSION
The bacteria isolated from the female urinary bladder include an abundance of
bacteriophages. Considering just those phage sequences predicted with high conﬁ-
dence, the number of phage sequences exceeded that of the number of bacterial
genomes examined. The abundance of prophage sequences within the urinary bacte-
rial strains may be the result of the bladder itself; lysogeny may serve as a survival
strategy when the bacterial community density is low or in the presence of other
environmental parameters, e.g., temperature and metabolic community composition
(39–42). Nevertheless, not all genomes examined in this study were found to contain
phage sequences; in fact, 13.8% of the bacterial isolates from the bladder did not
include any detectable phage sequence, and an additional 22% only contained phage
sequences predicted at the lower-conﬁdence level (see Data Set S3 in the supplemental
material). Taxa that did not show any evidence of phage infection included all three
Dolosicoccus paucivorans strains examined and several, but not all, isolates of Gardner-
TABLE 2 Sequence examination of high-conﬁdence phages within the genome of E. coli
UMB0901
Category Length (bp) Best blast hit
Accession
no. Identity (%) Query cover (%)
4 38,132 Escherichia coli K-15W01 CP016358 98 84
Salmonella phage STYP2 KX833213 97 58
5 10,493 E. coli ECONIH2 CP014667 99 100
E. coli K-15KW01 CP016358 99 99
5 63,683 E. coli 536 CP000247 99 100
E. coli ECONIH2 CP014667 99 100
5 69,863 E. coli 542 CP018970 99 99
E. coli ECONIH2 CP014667 99 88
FIG 4 TEM of phage isolated from bladder strain E. coli UMB0901.
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ella vaginalis andMicrococcus luteus. At present, a lytic phage from either D. paucivorans
or G. vaginalis has yet to be characterized, although prophage sequences within
Gardnerella spp. have previously been described (33). In contrast, a few phages capable
of lysing Micrococcus strains were isolated and studied in the 1960s and 70s (see, e.g.,
references 46 to 48). The 226 phages predicted with high conﬁdence were exclusive to
just 116 of the genomes examined. No correspondence between the presence/absence
of CRISPR arrays and prophage was observed (Data Set S1). While prior studies of the
microbiomes of other niches have found a correlation between bacterial genome size
and the number of prophages in genomes (49, 50), the strains from the bladder did not
ﬁt this expectation.
Whereas the number of phage sequences per genome varied, Lactobacillus strains
from the bladder frequently harbored more than one phage. For example, Lactobacillus
jensenii strain UMB0077 was the most phage-rich genome examined, with 10 phages
predicted at high conﬁdence and another three phages at lower conﬁdence (Data Set
S3). Surveys of the urinary microbiome have routinely found Lactobacillus species and
provided evidence of their association with urinary symptoms (6, 35, 51–54). Lactoba-
cilli also are dominant organisms within other niches, most notably the vagina (4, 55),
and some species have direct correlations to health outcomes (56–58). Microbiome
studies, particularly of the vaginal community, have discovered lytic phages of human-
associated Lactobacillus species (see, e.g., references 59 to 61). While some of the
Lactobacillus phages found in our study showed sequence homology to the previously
characterized Lactobacillus phage Lv1 (60), 15 Lactobacillus phage sequences predicted
with high conﬁdence exhibited no sequence similarity to any known lytic or lysogenic
phage. The fact that these urinary Lactobacillus genomes include prophages that have
yet to be found within vaginal lactobacilli leads us to posit that a subset of the
microbiota of these two niches may be isolated.
In addition to these novel Lactobacillus phages, novel phage genomes were also
identiﬁed within other bacteria common to the urinary microbiome (5, 6, 36, 51, 62),
including species of Actinomyces and Varibaculum (Fig. 2), Biﬁdobacterium, Gardnerella,
and Streptococcus, as well as the uropathogen Proteus mirabilis (Data Set S3). This
suggests a rich diversity of uncharacterized phage species present in the bladder,
conﬁrming prior conclusions of viral metagenomic analyses of urine samples (24, 25).
This observation is not unique to the bladder virome, as approximately 50% of the
phages within the gut virome cannot be classiﬁed (14). The phages isolated in prior
studies (22, 25) and the single phage reported here (Fig. 4) are limited to two of the 51
bacterial genera found within the bladder. For many of the species within the bladder,
there are no characterized lytic phages, and the ability for prophages to enter the lytic
cycle is unknown. Thus, to understand intracommunity interactions, it is imperative to
isolate and characterize phages from the bladder.
Further investigation into the diversity of phages within the bladder could provide
critical information concerning shifts in bladder community structure. Recent studies
have found that changes in the gut’s phage population may be associated with
dysbiosis and disease (11, 14, 63–65). Similar observations have been made from
studies of the vaginal microbiota (4). Furthermore, prior studies have suggested that
Lactobacillus phages could play a role in the shift in the vaginal community structure
and contribute to bacterial vaginosis (for a review, see reference 66). The bacterial
communities within the gut, vagina, and other areas targeted in the HMP are, however,
signiﬁcantly better characterized than those within the urinary bladder. The abundance
of lysogenic phages found in the bladder suggests that phages also may contribute to
urinary microbiota stability. Furthermore, the variation observed between the phage
populations within the strains selected of individuals with and without OAB symptoms
(Fig. 3), although not found to be statistically signiﬁcant, suggests that phages may
contribute to urinary health, thus warranting further study, including sequencing of
multiple strains and species of genera found within both populations.
While metagenomic studies can comprehensively sample microbial communities,
culture-dependent studies provide a key piece of information when investigating
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phages, namely, information regarding the bacterial host. For example, in this study, we
can associate each phage with at least one of its native host species. This includes the
129 novel and 140 putative phages that exhibit no sequence homology to any known
annotated (pro)phage sequence in public sequence repositories (Data Sets S5 and S6).
For those phages that do resemble a previously sequenced phage, the bacterial and/or
phage sequences recognized are typically annotated as the same bacterial host, e.g.,
the prophages of E. coli strain UMB0901 most closely resemble prophages within other
E. coli strains (Table 2). However, the sequence homology observed for the Actinomy-
cetaceae phages (Fig. 2) suggests that their host range might extend across genera and
even across taxonomic families. Similarly, analysis of two prophage sequences from
Actinomyces turicensis strain UMB0250 and Corynebacterium sp. strain UMB0763 sug-
gested that these phages may also be capable of infecting bacterial species of different
families (Data Set S5). These ﬁndings suggest that some phages within the microbiota
of the bladder may have a broad host range and should guide subsequent experimen-
tal work to test this hypothesis. While the notion of broad-host-range phages is
controversial within the phage research community (67), bioinformatic and experimen-
tal studies have identiﬁed such phages (68–70). Host range itself is likely transient, as
ecological factors, including drug treatment, may enable a phage’s ability to infect a
new bacterial host (71).
Our survey of lysogenic phages provides the ﬁrst step in the process of unraveling
the complex dynamics of phage-bacterium interactions within the urinary microbiota.
Additional sequencing of the bacterial population within the bladder, coupled with
further metagenomic sequencing of the urinary virome, is needed to both determine
if a core “bladder phageome” exists and whether phages play a role in urinary health
and disease.
MATERIALS AND METHODS
Bacterial isolates. The genome sequences examined in this study were of bacterial isolates isolated
from urine collected during the conduct of several institutional review board (IRB)-approved studies. In
the majority of cases, urine was collected aseptically via transurethral catheter. In a few cases, urine was
collected by midstream void. In either case, the urine sample was placed in a BD Vacutainer Plus C&S
preservative tube for culturing. Expanded quantitative urine culture (EQUC) was performed as described
previously (36). Matrix-assisted laser desorption ionization–time of ﬂight mass spectrophotometry
(MALDI-TOF MS) with the MALDI Biotyper 3.0 software program (Bruker Daltonics, Billerica, MA) was used
to identify the bacterial strains selected for sequencing, as described elsewhere (36).
Isolates were collected from individuals with or without lower urinary tract symptoms (LUTS). LUTS
included overactive bladder (OAB; n  101), interstitial cystitis/painful bladder syndrome (IC/PBS; n  1),
depression with diabetes (DD; n  1), stress urinary incontinence (SUI; n  2), or urinary tract infection
(UTI; n  6). One isolate was from a patient presenting with a kidney stone. Individuals without LUTS
(n  69) included a small cohort of pregnant women (n  16). Thirty-nine of the samples collected were
from individuals after LUTS treatment. The patient symptom status using these codes is indicated for
each isolate in Data Set S1 in the supplemental material.
Genome sequencing and assembly. Genome sequencing and assembly are described in full by
Thomas-White et al. (unpublished). Brieﬂy, the bacterial isolates were grown in their preferred medium
and pelleted. Genomic DNA was extracted using a phenol-chloroform method (72). Genome sequencing
was completed at the Wellcome Trust Genome Campus (Hinxton, UK). The Illumina Nextera kit was used
for whole-genome library preparation with fragment sizes of 200 to 300 bp. Sequencing was conducted
on the Illumina HiSeq 2000 platform, producing paired-end 2 100-bp reads, and annotated assemblies
were produced using the pipeline described previously (73). Sequence reads were used to create
multiple assemblies using VelvetOptimiser version 2.2.5 (74) and Velvet version 1.2 (75). The assembly
with the best N50 score was selected, and an assembly improvement step was performed using the tools
SSPACE (76) and GapFiller (77). Additionally, we computed the genome coverage using BBMap (78).
All reads and assemblies are publicly available via EBI and GenBank; accession numbers are listed in
Data Set S1.
Phylogenetic analysis. Taxonomic classiﬁcation of isolates was performed based upon the ge-
nome’s 16S rRNA gene sequence. 16S rRNA gene sequences were detected through blastn queries to a
local copy of the 16S rRNA gene sequences from the RNAmmer server (79). The bacterial isolates’
sequences were aligned via CLUSTALW through Geneious version 9.1.4 (Auckland, New Zealand). A
phylogenetic tree was derived using FastTree (80) through Geneious using the Jukes-Cantor model. The
16S rRNA gene sequences used for construction of this tree are included in Data Set S2. The tree was
visualized using PhyloWidget (81).
CRISPR analysis of bacterial genomes. CRISPR spacer arrays were detected using the software
minCED (82). Arrays containing three or more spacers were identiﬁed.
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Phage identiﬁcation and characterization. Contigs were examined using the tool VirSorter (43).
Brieﬂy, VirSorter examines sequences, looking for hallmark viral genes (e.g., capsid protein, terminase
large subunit, and tail) and enrichment in virus-like genes. VirSorter predictions include conﬁdence
categories. Viral sequences, either prophages that remain in the cytoplasm in plasmid form or as lytic
phages, are identiﬁed as category 1, 2, and 3 phages, corresponding to predictions that are “most
conﬁdent,” “likely,” and “possible,” respectively. Categories 4, 5, and 6 are reserved for prophage
sequences detected within a cellular contig. Category 4 refers to the most conﬁdent predictions, whereas
categories 5 and 6 correspond to likely and possible predictions, respectively. Further details regard-
ing these categories can be found online (https://pods.iplantcollaborative.org/wiki/display/DEapps/
VIRSorter1.0.2).
All VirSorter-predicted sequences were compared via blastn to all bacterial nucleotide sequences
(query: “bacteria[ﬁlter] AND ddbj_embl_genbank[ﬁlter]”) and viral RefSeq (83) genomic sequences,
collected in June 2017, and run locally. Phage sequences were also compared locally via blastx to
annotated terminase protein sequences within the RefSeq viral collection. Predicted phage sequences of
interest were further examined using the RAST annotation server (44), with blast queries of the complete
nr/nt database via NCBI and by manual inspection. Upon manual curation, no sequences were found to
be obvious misclassiﬁcations of viral sequences. VirSorter-predicted sequences were compared using
reciprocal blastn queries locally to identify syntenic regions between the phage sequences. Phage
sequences identiﬁed with a query coverage of 50% were clustered and examined further in Geneious
via sequence alignment using Mauve (84).
Statistical analysis. Two negative binomial distributions with different parameters were used to
model the probability mass functions of the number of phage sequences observed in the two samples:
patients with and without LUTS. Then, a generalized likelihood ratio test was performed to test the
hypothesis that their centrality parameters are equal, assuming they have the same dispersion (85). This
means that we were testing whether the overall probability distribution of the number of phage
sequences is the same in the two groups. A Wilcoxon test was performed to test for differences in the
mean number of phage sequence counts between the control and disorder groups for each bacterial
genus.
Phage isolation and characterization. E. coli isolates from the bladder were retrieved from 80°C
storage, streaked on 1.7% LB agar plates, and incubated overnight at 37°C. Individual colonies were
selected to inoculate ﬂasks of LB medium and grown overnight with shaking at 120 rpm and 37°C.
Cultures were then centrifuged, and the supernatant was ﬁltered using 0.2-m-pore-size cellulose
acetate ﬁlters. Pour plates of the supernatant were made using laboratory strains of E. coli, including
E. coli C (obtained from C. Burch, University of North Carolina), E. coli B (Ward’s, VWR), and E. coli K-12
(ATCC 25404). These plates were prepared as follows: 3 ml of LB soft agar (0.7% agar), 500 l of the
respective E. coli culture (C, B, or K-12), and 100 l of supernatant were poured atop a 1.7% LB agar
plate. Plating was performed with E. coli cultures suspended during exponential growth or stationary
phase.
Plaques were identiﬁed from the ﬁltrate of the E. coli strain UMB0901 plated on E. coli C plates.
The LB soft agar overlay was harvested and resuspended in LB. Phage stock was grown in high titer
and triple ﬁltered (as described above) for microscopy. Puriﬁed viral lysate was applied to Pioloform-
coated copper grids and left to dry at room temperature. Samples were positively stained with 2%
(wt/vol) uranyl acetate (86) and observed at 80 kV using a Hitachi H-600 transmission electron
microscope (TEM).
Accession number(s). Raw sequencing reads are available through the NCBI under BioProject no.
PRJNA316969 (https://www.ncbi.nlm.nih.gov/bioproject/PRJNA316969) and EMBL-EBI under accession
no. PRJEB8104 (http://www.ebi.ac.uk/ena/data/view/PRJEB8104). Individual accession numbers for each
isolate sequenced are listed in Data Set S1. Assembled genomes can be accessed via the PRJNA316969
BioProject link. The accession numbers for each individual assembled genome are also listed in Data
Set S1.
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